Advanced search
Publication Cover
Cancer Investigation Volume 37, 2019 - Issue 2
Submit an article Journal homepage
103
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer

R. Charles NicholsDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA; ;University of Florida Health Proton Therapy Institute, Jacksonville, Florida, USA; Correspondence[email protected]
,
Christopher G. MorrisDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA; ;University of Florida Health Proton Therapy Institute, Jacksonville, Florida, USA;
,
Curtis BryantDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA; ;University of Florida Health Proton Therapy Institute, Jacksonville, Florida, USA;
,
Bradford S. HoppeDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA; ;University of Florida Health Proton Therapy Institute, Jacksonville, Florida, USA;
,
Randal H. HendersonDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA; ;University of Florida Health Proton Therapy Institute, Jacksonville, Florida, USA;
,
William M. MendenhallDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA; ;University of Florida Health Proton Therapy Institute, Jacksonville, Florida, USA;
,
Zuofeng LiDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA; ;University of Florida Health Proton Therapy Institute, Jacksonville, Florida, USA;
,
Joseph A. CostaDepartment of Urology, University of Florida College of Medicine, Jacksonville, Florida, USA
,
Christopher R. WilliamsDepartment of Urology, University of Florida College of Medicine, Jacksonville, Florida, USA
&
Nancy P. MendenhallDepartment of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida, USA; ;University of Florida Health Proton Therapy Institute, Jacksonville, Florida, USA;
show all
Pages 85-89 | Received 20 Nov 2018, Accepted 27 Dec 2018, Published online: 05 Mar 2019

References

  • Zagars GK, Pollack A. Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1997;39(1):85–89.
  • Daniell HW, Clark JC, Pereira SE, Niazi ZA, Ferguson DW, Dunn SR, et al. Hypogonadism following prostate-bed radiation therapy for prostate carcinoma. Cancer. 2001;91(10):1889–1895.
  • Pickles T, Graham P; Members of the British Columbia Cancer Agency Prostate Cohort Outcomes I. What happens to testosterone after prostate radiation monotherapy and does it matter? J Urol. 2002;167(6):2448–2452. doi:10.1016/S0022-5347(05)65002-1.
  • Oermann EK, Suy S, Hanscom HN, Kim JS, Lei S, Yu X, et al. Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer. J Hematol Oncol. 2011;4(1):12. doi:10.1186/1756-8722-4-12.
  • Markovina S, Weschenfelder DC, Gay H, McCandless A, Carey B, DeWees T, Knutson N, et al. Low incidence of new biochemical hypogonadism after intensity modulated radiation therapy for prostate cancer. Pract Radiat Oncol. 2014;4(6):430–436. doi:10.1016/j.prro.2014.02.004.
  • Planas J, Celma A, Placer J, Maldonado X, Trilla E, Salvador C, et al. Hormonal changes after localized prostate cancer treatment. Comparison between external beam radiation therapy and radical prostatectomy. Actas Urol Esp. 2016;40(9):549–555. doi:10.1016/j.acuro.2016.02.010.
  • Pompe RS, Karakiewicz PI, Zaffuto E, Smith A, Bandini M, Marchioni M, et al. External beam radiotherapy affects serum testosterone in patients with localized prostate cancer. J Sex Med. 2017;14(7):876–882. doi:10.1016/j.jsxm.2017.04.675.
  • Nichols RC, Hu C, Bahary JP, Zeitzer KL, Souhami L, Leibenhaut MH, et al. Serum testosterone changes in patients treated with radiotherapy alone for prostate cancer on nrg oncology rtog 9408. Adv Radiat Oncol. 2017;2(4):608–614. doi:10.1016/j.adro.2017.07.004.
  • Nichols RC, Morris CG, Hoppe BS, Henderson RH, Marcus RB, Mendenhall WM, et al. Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression. Int J Radiat Oncol Biol Phys. 2012;82(3):1222–1226. doi:10.1016/j.ijrobp.2010.12.025.
  • Kil WJ, Nichols RC, Hoppe BS, Morris CG, Marcus RB, Mendenhall W, et al. Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression. Acta Oncol. 2013;52(3):492–497. doi:10.3109/0284186X.2013.767983.
  • Mendenhall NP, Hoppe BS, Nichols RC, Mendenhall WM, Morris CG, Li Z, et al. Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014;88(3):596–602. doi:10.1016/j.ijrobp.2013.11.007.
  • Henderson RH, Bryant C, Hoppe BS, Nichols RC, Mendenhall WM, Flampouri S, et al. Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer. Acta Oncol. 2017;56(7):963–970. doi: 10.1080/0284186X.2017.1287946.
  • Rowley MJ, Leach DR, Warner GA, Heller CG. Effect of graded doses of ionizing radiation on the human testis. Radiat Res. 1974;59(3):665–678.
  • Shapiro E, Kinsella TJ, Makuch RW, Fraass BA, Glatstein E, Rosenberg SA, et al. Effects of fractionated irradiation of endocrine aspects of testicular function. J Clin Oncol. 1985;3(9):1232–1239. doi:10.1200/JCO.1985.3.9.1232.
  • Taira AV, Merrick GS, Galbreath RW, Butler WM, Lief JH, Allen ZA, et al. Serum testosterone kinetics after brachytherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012;82(1):e33–e38. doi: 10.1016/j.ijrobp.2011.01.027.
  • Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65(1):1–7. doi:10.1016/j.ijrobp.2006.01.027.
  • Paganetti H, Bortfeld T, Delaney TF. Neutron dose in proton radiation therapy: in regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1-7). Int J Radiat Oncol Biol Phys. 2006;66(5):1594–1595. Author reply 5. doi:10.1016/j.ijrobp.2006.08.005.
  • Yoon M, Ahn SH, Kim J, Shin DH, Park SY, Lee SB, et al. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy. Int J Radiat Oncol Biol Phys. 2010;77(5):1477–1485. doi: 10.1016/j.ijrobp.2009.07.011.
  • Hoppe BS, Harris S, Rhoton-Vlasak A, Bryant C, Morris CG, Dagan R, et al. Sperm preservation and neutron contamination following proton therapy for prostate cancer study. Acta Oncol. 2017;56(1):17–20. doi: 10.1080/0284186X.2016.1205219.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.